TwitterFacebookLinkedIn
IGCS Members and Friends, I am extremely proud to announce on behalf of the IGCS leadership that the Impact Factor for the International Journal of Gynecological Cancer increased to 5.4, the Impact Factor in 2024 was 4.7. Dr. Pedro Ramirez became the IJGC Editor in Chief in January 2019. We’d like to congratulate him on this achievement and applaud the efforts of the Associate Editors, Editorial Board and our Publisher, Elsevier. IGCS President Professor Greta Dreyer commented, “This milestone is a celebration of the entire IJGC community — the authors, reviewers, and editors who invest their time and expertise in advancing gynecologic cancer science. An impact factor of 5.4 demonstrates that our journal is where meaningful, citable research happens.” Dr. Pedro Ramirez shares his sentiments: “Our team is extremely proud of this achievement, and we are grateful for all the great investigators who contributed their great work to our journal. Achieving an impact factor of 5.4 is a direct reflection of the outstanding science our contributors bring to IJGC. I am deeply grateful to our authors, Associate Editors, Editorial Board, IJGC Fellows, and our partners at Elsevier, IGCS and ESGO for their continued commitment to excellence.” IJGC is a scientific publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces. Learn more and submit your work to the International Journal of Gynecological Cancer. Make sure you are taking advantage of all the benefits of being a subscriber to IJGC including weekly podcasts, monthly Zoom journal club discussions and YouTube recordings. IJGC is also active on social media! Be sure to follow along on Instagram, LinkedIn and Twitter! Again, congratulations to Pedro and the entire IJGC team!
Mary Eiken, MS IGCS CEO

Leave a Reply